Work

158 POSTER Abiraterone acetate (AA), an irreversible inhibitor of CYP17, has significant and durable anti-tumor activity in both chemotherapy- naive and docetaxel treated castration-resistant prostate cancer (CRPC)

Year: 2008

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(08)72090-1

Authors: G. Attard, A. Reid, N. Babu Oommen, L. Folkerd, D. Olmos, E. Thompson, G. Maier, M. Dowsett, D. Dearnaley, J.S. De Bono

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2019695633

Cites:

Cited by:

Related to: 10